|
| 37953380 | DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms. | Nucleic Acids Res | 2024 |
| 36251745 | Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. | Blood Adv | 2023 |
| 37910143 | Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. | Cancer Res Commun | 2023 |
| 37487666 | Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment. | J Immunother Cancer | 2023 |
| 37954974 | Normalization of drug and therapeutic concepts with Thera-Py. | JAMIA Open | 2023 |
| 37824796 | Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case Report. | JCO Precis Oncol | 2023 |
| 37493986 | Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303. | Blood Adv | 2023 |
| 37810214 | Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer. | iScience | 2023 |
| 36949070 | Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer. | Nat Commun | 2023 |
| 37317137 | Metagenomic Analysis of DNA Viruses with Targeted Sequence Capture of Canine Lobular Orbital Adenomas and Normal Conjunctiva. | Microorganisms | 2023 |
| 37279078 | T-BET and EOMES sustain mature human NK cell identity and antitumor function. | J Clin Invest | 2023 |
| 37034778 | Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer. | bioRxiv | 2023 |
| 37266381 | Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma. | Front Vet Sci | 2023 |
| 37027480 | Computational prediction of MHC anchor locations guides neoantigen identification and prioritization. | Sci Immunol | 2023 |
| 36890230 | Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapy. | Nature | 2023 |
| 36373660 | CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase. | Nucleic Acids Res | 2023 |
| 34780623 | Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma. | Blood | 2022 |
| 35475554 | Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau disease. | Hum Mutat | 2022 |
| 35366592 | Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions. | Cancer Genet | 2022 |
| 35494251 | Integrative genomic analysis reveals low T-cell infiltration as the primary feature of tobacco use in HPV-positive oropharyngeal cancer. | iScience | 2022 |
| 35568002 | Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers. | Cancer Genet | 2022 |
| 35624339 | A community approach to the cancer-variant-interpretation bottleneck. | Nat Cancer | 2022 |
| 36617634 | Estimation of intrafamilial DNA contamination in family trio genome sequencing using deviation from Mendelian inheritance. | Genome Res | 2022 |
| 36273232 | Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer. | Sci Rep | 2022 |
| 36063163 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 35101336 | Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC). | Genet Med | 2022 |
| 35058328 | Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders. | J Immunother Cancer | 2022 |
| 34871371 | Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant. | Blood | 2022 |
| 35196021 | Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia. | Sci Transl Med | 2022 |
| 34610950 | Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis. | Cancer Discov | 2022 |
| 33237278 | Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. | Nucleic Acids Res | 2021 |
| 35611186 | <i>In silico</i> epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccines. | Cancer Res Commun | 2021 |
| 33547198 | Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas. | Clin Cancer Res | 2021 |
| 33653917 | Genetic Ancestry Correlations with Driver Mutations Suggest Complex Interactions between Somatic and Germline Variation in Cancer. | Cancer Discov | 2021 |
| 33556121 | Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches. | PLoS One | 2021 |
| 33832946 | Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma. | Clin Cancer Res | 2021 |
| 35072136 | GA4GH: International policies and standards for data sharing across genomic research and healthcare. | Cell Genom | 2021 |
| 35311178 | The GA4GH Variation Representation Specification: A computational framework for variation representation and federated identification. | Cell Genom | 2021 |
| 34957471 | Sex- and mutation-specific p53 gain-of-function activity in gliomagenesis. | Cancer Res Commun | 2021 |
| 34506690 | Exploring the Genomic Landscape of Cancer Patient Cohorts with GenVisR. | Curr Protoc | 2021 |
| 34036230 | Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia. | JCO Precis Oncol | 2021 |
| 34341766 | Bam-readcount - rapid generation of basepair-resolution sequence metrics. | ArXiv | 2021 |
| 34173924 | Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer. | Breast Cancer Res Treat | 2021 |
| 34029233 | Multitarget Stool RNA Test for Noninvasive Detection of Colorectal Neoplasias in a Multicenter, Prospective, and Retrospective Cohort. | Clin Transl Gastroenterol | 2021 |
| 33397681 | Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial. | Clin Cancer Res | 2021 |
| 32180547 | Wikidata as a knowledge graph for the life sciences. | Elife | 2020 |
| 31907209 | pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens. | Cancer Immunol Res | 2020 |
| 31902496 | A virome sequencing approach to feline oral squamous cell carcinoma to evaluate viral causative factors. | Vet Microbiol | 2020 |
| 33040078 | Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation. | Cell Death Dis | 2020 |
| 32665297 | Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial. | Clin Cancer Res | 2020 |